Company news

Allergy Therapeutics plc news in 2021

Allergy Therapeutics plc's news releases, calls and decks from 2021, newest first.

View company

Allergy Therapeutics: Granting of Awards

November 25, 2021

Director Dealings

November 11, 2021

Cheryl MacDiarmid appointed to Board of Directors

October 27, 2021

Allergy announces positive G309 results

October 25, 2021

Annual Report and AGM Notification

October 7, 2021

Preliminary Results for Year ended 30 June 2021

September 23, 2021

ImmunoBON voted Most Innovative Product of 2021

September 16, 2021

Secondary endpoints from VLP Peanut 001

September 13, 2021

Allergy to Present at H.C. Wainwright Conference

September 9, 2021

Allergy to host KOL webinar on VLP Peanut

September 7, 2021

Successful primary outcome of VLP Peanut 001

August 3, 2021

Trading update for the year ended 30 June 2021

July 14, 2021

AGY to present key scientific findings at EAACI

July 8, 2021

Trading Update

June 24, 2021

Completion of treatment phase in G309 study

May 6, 2021

Appointment of new Group auditors

April 19, 2021

Appointment of new Group auditors

April 16, 2021

Vesting of Awards under Long Term Incentive Plan

March 31, 2021

Pledge of Shares

March 26, 2021

AGY to Present at H.C. Wainwright Conference

March 8, 2021

Interim Results for six months ended 31 Dec 2020

March 3, 2021

Block Listing Return and Total Voting Rights

January 15, 2021

Half Year Trading Update 2021 & Notice of Results

January 13, 2021

Initiation of peanut allergy biomarker study

January 5, 2021

Decks in 2021